Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAI-VP705 vaccine for parvovirus B-19 infection
NCT00379938Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2006
- Primary completion
- Oct 2008
- Countries
- 1
01
Overview
A Phase 2 trial of VAI-VP705 in parvovirus B19 infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2006; status: terminated.
02
Drugs
VAI-VP705
03
Conditions
parvovirus B19 infection
Beyond the preview
Go deeper on NCT00379938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379938.